• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novelix Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 33252.0
  • ISIN : INE314I01036
41.30 -2 (-4.31%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    41.25

  • Today’s High

    44.00

  • Open

    42.20

  • Perv Close

    43.16

  • 52W Low

    19.88

  • 52W High

    52.79

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    103.04

  • Div & Yield %

    0.00

  • Book Value(₹)

    13.04

  • Debt-Equity Ratio

    -4.31

  • AGM Date

    25-Jul-2025

  • EPS

    0.03

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    103.04

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.95

  • BV (₹)

    13.00

  • Sales( ₹ in Cr.)

    30.72

  • NP (in Cr.)

    0.08

  • NP Var(%)

    480.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    103.04

  • 52 Week High

    52.79

  • 52 Week Low

    19.88

  • Price BSE

    41.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    103.04

  • P/C Ratio

    835.10

  • P/E Ratio

    1,210.60

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 4.49 1.92 1.14 1.31 1.50 3.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4.49 1.92 1.14 1.31 1.50 3.61
Other Income 0.04 0.00 0.25 0.00 0.00 0.11
Stock Adjustments 0.37 0.29 0.28 -0.14 -0.02 0.00
Total Income 4.90 2.21 1.67 1.17 1.48 3.72
EXPENDITURE :            
Raw Materials 4.21 1.64 1.09 0.88 0.73 2.77
Power and Fuel Cost 0.00 0.01 0.01 0.01 0.02 0.00
Employee Cost 0.13 0.16 0.14 0.15 0.13 0.18
Other Manufacturing Expenses 0.02 0.02 0.02 0.03 0.05 0.03
Selling and Administration Expenses 0.34 0.36 0.38 0.31 0.35 0.42
Miscellaneous Expenses 0.14 0.01 1.53 2.98 0.01 0.02
Employee Benefit Expenses 0.13 0.16 0.14 0.15 0.13 0.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4.85 2.21 3.17 4.36 1.29 3.41
Operating Profit 0.06 0.00 -1.49 -3.19 0.18 0.31
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.06 0.00 -1.49 -3.19 0.18 0.31
Depreciation 0.04 0.06 0.07 0.08 0.08 0.12
Profit Before Tax 0.02 -0.06 -1.56 -3.27 0.10 0.19
Current Tax 0.00 0.00 0.00 0.00 0.01 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.00 -0.01 0.00 0.01 -0.10
Reported Net Profit 0.01 -0.06 -1.56 -3.27 0.09 0.25
Extraordinary Items 0.03 0.00 -0.02 0.00 0.00 0.09
Adjusted Net Profit -0.02 -0.06 -1.54 -3.27 0.09 0.16
Adjustment below Net Profit 0.15 0.01 0.00 0.00 -0.03 -0.06
P & L Balance brought forward -2.43 -2.37 -0.81 2.53 2.50 2.25
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.14 0.01 0.00 0.07 0.03 -0.06
P & L Balance carried down -2.41 -2.43 -2.37 -0.81 2.53 2.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.01 -0.07 -1.93 -4.04 0.12 0.31
Earnings Per Share(Adj)-Unit Curr 0.01 -0.07 -1.93 -4.04 0.12 -
Book Value 9.08 8.88 8.94 10.87 14.90 14.83
Book Value(Adj)-Unit Curr 9.08 8.88 8.94 10.87 14.90 -

Shareholding Pattern

  • Promoter Group

    52.75%

  • Public Share Holding

    47.25%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,002,000 38.67 5,002,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,820,733 14.08 1,820,733 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,822,733 52.75 6,822,733 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,143,334 8.84 1,135,234 20
Clearing Members 635 0.00 635 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 31,929 0.25 31,929 5
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 23,894 0.18 23,894 26
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,831,398 29.62 3,797,698 30
Individuals holding nominal share capital up to Rs. 1 lakh 931,770 7.20 647,160 2,318
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 135,000 1.04 135,000 1
Sub Total 6,112,267 47.25 5,785,857 2,403
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,935,000 100.00 12,608,590 2,408

Company Background

Novelix Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Novelix Pharmaceuticals Ltd
  • BSE Code : 33252.0
  • ISIN : INE314I01036

  • Incorporation Year

    1994

  • Registered Office

    4-4-231/1/2/ABC Inderbagh
    Sultan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-24757370

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Nishita Kalantri

  • Auditor

    CVS Bala Chandra Rao & Co/P Murali & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Novelix Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novelix Pharma. 41.30 4.53 4.22 1,376.67 -0.24
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10